Amaranthus viridis Ameliorates Oxidative Stress and Modulates TNF-β in Tramadol- Induced Testicular Toxicity
Abstract
Background: Tramadol, a synthetic opioid analgesic, is associated with reproductive toxicity and testicular oxidative damage following prolonged exposure. Amaranthus viridis (green amaranth), a medicinally valued tropical vegetable, possesses antioxidant and anti-inflammatory properties that may offer protective effects. This study investigated the protective potential of Amaranthus viridis leaf extract against tramadol-induced testicular toxicity in adult male Wistar rats, focusing on oxidative stress biomarkers, reproductive hormones, and inflammatory cytokines. Method: Twenty-five adult male Wistar rats were randomly assigned into five groups (n=5). Group 1 received distilled water (control); Group 2 received 200 mg/kg tramadol (toxic control); Groups 3, 4, and 5 were administered combined doses of tramadol (150, 100, and 50 mg/kg, respectively) and Amaranthus viridis extract (100, 200, and 300 mg/kg, respectively) for 21 days via oral gavage. Testicular tissues and serum samples were evaluated for histology, oxidative stress markers (SOD, GPx, MDA), reproductive hormones (LH, FSH, testosterone), and inflammatory cytokines (IL-1, IL-6, TNF-α, TNF-β). Results: Tramadol administration significantly disrupted testicular histoarchitecture and caused a marked reduction in LH, FSH, testosterone, SOD, and GPx levels, along with elevated MDA and TNF-β levels (p<0.05). Co-treatment with A. viridis extract, especially at 300 mg/kg, significantly restored LH, FSH, testosterone, SOD, and GPx levels and suppressed TNF-β expression, although MDA levels remained elevated. Histologically, A. viridis treatment attenuated germ cell necrosis and improved seminiferous tubule integrity. Conclusion: A. viridis extract demonstrated a dose-dependent protective effect against tramadol-induced testicular toxicity by enhancing antioxidant defenses, restoring hormonal balance, and suppressing proinflammatory cytokines-highlighting its therapeutic potential in male reproductive health.
Keywords
References
- 1. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923.
- 2. Akinyemi JO, Owoaje ET, Cadmus EO. Trends in prevalence and correlates of non-medical use of prescription opioids among university students in southwestern Nigeria. Afr J Drug Alcohol Stud. 2019;18(1):11-22.
- 3. Abdel-Zaher AO, Abdel-Rahman MS, Elwasei FM. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress. Toxicology. 2018;252(1-3):45-52.
- 4. Atici S, Aydin D, Sahin F. Tramadol-induced testicular toxicity in rats: role of oxidative stress and nitric oxide. Toxicol Ind Health. 2005;21(7-8):161-167.
- 5. El-Gaafarawi IM. Biochemical toxicity induced by tramadol administration in male rats. Egypt J Hosp Med. 2006;23(1):353-362.
- 6. Salman TM, Fadare OA, Jimoh AG. Tramadol-induced testicular oxidative damage and the potential protective role of antioxidants. Afr J Biomed Res. 2021;24(1):65-73.
- 7. Elsawy MM, Elgohary RO, Elbadry MI, Abdelaziz AA. Tramadol administration induces reproductive toxicity and suppresses hypothalamic-pituitary-gonadal axis in adult male rats. Andrologia. 2020;52(4):e13543.
- 8. Awadalla EA, Mohamed AM. Tramadol-induced testicular toxicity in adult male albino rats: histopathological and biochemical studies. J Exp Clin Anat. 2016;15(1):1-7.
Details
Primary Language
English
Subjects
Family Medicine
Journal Section
Research Article
Authors
Vershima Kiekwe
*
0000-0003-1544-4176
Nigeria
Gabriel Idoko
0009-0003-6784-0290
Nigeria
Gabriel Akunna
0000-0001-6476-4657
Nigeria
Publication Date
March 31, 2026
Submission Date
November 26, 2025
Acceptance Date
March 16, 2026
Published in Issue
Year 1970 Volume: 48 Number: 1